Cessation of pulmonary vasodilators in PAH related to congenital heart disease
Pulmonary arterial hypertension secondary to congenital heart diseases is a subset of patients who need pulmonary vasodilators (PVDs). We are reporting an adult female who continued to have severe pulmonary hypertension after corrective surgery for the atrial septal defect. She showed improvement in...
Main Authors: | Immaneni Sathyamurthy, K Kirubakaran, Sasikala Subramanian, K N Srinivasan |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2023-01-01
|
Series: | Journal of Indian College of Cardiology |
Subjects: | |
Online Access: | http://www.joicc.org/article.asp?issn=1561-8811;year=2023;volume=13;issue=1;spage=40;epage=42;aulast=Sathyamurthy |
Similar Items
-
Evidence base for specific pulmonary vasodilators in adults with congenital heart disease
by: Anton A. Shmalts, et al.
Published: (2021-09-01) -
PAH-specific therapy for pulmonary hypertension and interstitial lung disease: A systemic review and meta-analysis
by: Ning Zhao, et al.
Published: (2022-11-01) -
Role of pulmonary rehabilitation in patients with pulmonary arterial hypertension
by: Gehan M El-Assal, et al.
Published: (2018-01-01) -
Pulmonary artery hypertension: A bedside review
by: Mohit Bhagwati, et al.
Published: (2021-01-01) -
Oxygen-Sensitivity and Pulmonary Selectivity of Vasodilators as Potential Drugs for Pulmonary Hypertension
by: Daniel Morales-Cano, et al.
Published: (2021-01-01)